Bold New Policies for The Brave New Biologies: IPRs and Innovation in Synthetic Biology and Gene editing
Research Seminar debating intellectual property and innovation in synthetic biology and gene editing.
New technologies in biology offer a brave new world of possibilities. Promising solutions to some of the most urgent challenges faced by humanity: climate change, environmental protection, growing population, renewable energy and improved health care. Scientific and technological progress has been remarkable. Simultaneously, emerging life science technologies raise outstanding ethical, legal and social questions.
In this research seminar, Prof. Esther Van Zimmeren from the University of Antwerp joins Prof. Timo Minssen, Postdoc Ana Nordberg and Ph.D. Student Jakob Wested from the Centre for Information and Innovation Law, debating bold new policies for intellectual property law and incentive to life science innovation.
|15:00 – 15:10||Welcome
Prof. Timo Minssen, CIIR, Faculty of Law, University of Copenhagen.
|15:10 – 15:30||Waiting for the Rumble in the Jungle: - An overview of current CRISPR/CAs9 patent disputes, central legal issues and some thoughts on conditioning the innovation system.
PhD Student Jakob Wested, CIIR, Faculty of Law, University of Copenhagen.
|15:30 – 15:50||From FRAND to FAIR for Synthetic and Systems Biology? The Implications of Openness, IP Strategies, Standardization and the Huawei-case.
Prof. Esther van Zimmeren, Faculty of Law, University of Antwerp.
|15:50 – 16:10||Keeping up with the technologies: IP Law and Regulation in the age of gene editing.
Postdoc Ana Nordberg, CIIR, Faculty of Law, University of Copenhagen.
|16.10 – 17.00||Questions and panel debate|
Time: 13 March 2017, 15:00 – 17:00
Contact: Ana Nordberg (email@example.com)